ABC | Volume 111, Nº6, December 2018

Original Article Santos et al OX-LDL and Oral Contraceptives Arq Bras Cardiol. 2018; 111(6):764-770 This is an open-access article distributed under the terms of the Creative Commons Attribution License and Health Promotion. Division of Nutrition and Physical Activity. [Internet]. Physical activity and health: a report of the Surgeon General. Executive Summary; 1996. [Cited in 2014 Dec 20]. Available from: http:// www.cdc.gov/nccdphp/sgr/summary.htm 19. Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al. [IV Brazilian Guideline for dyslipidemia and atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology]. Arq Bras Cardiol. 2007;88 Suppl 1:2-19. 20. WorldHealthOrganization. (WHO). Obesity: preventing andmanaging the global epidemic. Report of aWHO consultation. WorldHealthOrgan Tech Rep Ser. 2000;894:i-xii,1-253. 21. FriedewaldWT, Levy RI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. 22. Casazza GA, Suh SH, Miller BF, Navazio FM, Brooks GA. Effects of oral contraceptives on peak exercise capacity. J Appl Physiol (1985). 2002;93(5):1698-702. 23. CasellaM.Homemonitoringofbloodglucosebyownersofdiabeticcatsanddogs: technical problems and evaluation of differences between home and hospital bloodglucosecurves.[Tese].Zurique:FaculdadedeMedicinaVeterinária;2003. 24. Burtis CA, Bruns DE, Ashwood ER. Tietz. Fundamentos de química clínica. 6ª. ed. Rio de Janeiro: Guanabara- Koogan; 1998. 25. LeivaE,WehingerS,GuzmánL,OrregoR.RoleofoxidizedLDLinatherosclerosis, hypercholesterolemia.London:IntechOpenLimited,TheShard;2015. 26. Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb. 2003;10(3):186-91. 27. AndoziaMB, Vieira CS, Franceschini SA, Torqueti Tolloi MR, Silva de SáMF, Ferriani RA. Ethinylestradiol and estradiol have different effects on oxidative stress and nitric oxide synthesis in human endothelial cell cultures. Fertil Steril. 2010;94(5):1578-82. 28. Barbosa KB, VolpAC, Hermsdorff HH, Navarro-Blasco I, Zulet MÁ, Martínez JA, et al. Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational study. Lipids Health Dis. 2011 Apr 19;10:61. 29. Santos AC, Petto J, Oliveira FT, Diogo DP, Ladeia AM. C-reactive protein in oral contraceptive users: related factors and cardiovascular risk. Int J Cardiovasc Sci. 2016;29(4):320-5. 30. Godsland IF, Crook D, Simpson R, Proudler T, Felton C, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 1990;323(20):1375-81. 31. Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol. 1999;180(6 Pt 2):S343-8. 32. Oravec S, Dostal E, Dukát A, Gavorník P, Kucera M, Gruber K. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia. Neuro Endocrinol Lett. 2011;32(4):502-9. 33. Raitakari M, Mansikkaniemi K, Marniemi J, Viikari JS, Raitakari OT. Distribution and determinants of serumhigh-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study. J Intern Med. 2005;258(5):428-34. 34. Lubianca JN, Moreira LB, GusM, Fuchs FD. Stopping oral contraceptives: an effective blood pressure-lowering intervention inwomenwith hypertension. J HumHypertens. 2005;19(6):451-5. 35. Haroon S, Naveed KA. Effect of hormonal contraceptives on serum electrolytes and blood pressure. JPMI. 2014;28(4):409-13. 36. Uchida Y, Maezawa Y, Uchida Y, Hiruta N, Shimoyama E. Localization of oxidized low-density lipoprotein and its relation to plaque morphology in human coronary artery. PLoS One. 2013;8(2):e55188. 37. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340(2):115-26. 38. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-74. 39. LidegaardO, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic strokeandmyocardial infarctionwithhormonalcontraception.NEngl JMed. 2012;366(24):2257-66. 770